VIDA Global (VIDA) Stock Analysis & Winston Score
VIDA Global Inc. is a small technology company that uses artificial intelligence to analyze medical images, particularly chest X-rays and CT scans. Its software helps doctors and hospitals detect diseases like lung cancer and chronic obstructive pulmonary disease (COPD) more quickly. The company sells its tools to healthcare providers, research institutions, and pharmaceutical companies running clinical trials. VIDA makes money by licensing its AI software platform to customers, primarily in the United States. With a market cap of around $100 million, it is a very small player in the medical imaging software space, competing against much larger companies with deeper resources. The company is currently losing a significant amount of money relative to its revenue, as shown by its deeply negative operating margin, and its main challenge is scaling up sales fast enough to reach profitability before it runs out of runway.
Winston Score: 23/100 — Weak
Weak fundamentals across most pillars.
- Quality: Mixed (8/30)
- Growth: Weak (4/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $2.32
Market Cap: $46M
Sector: Technology
Industry: Software - Application

